300 related articles for article (PubMed ID: 32710190)
1. Multi-layered epigenetic regulation of IRS2 expression in the liver of obese individuals with type 2 diabetes.
Krause C; Geißler C; Tackenberg H; El Gammal AT; Wolter S; Spranger J; Mann O; Lehnert H; Kirchner H
Diabetologia; 2020 Oct; 63(10):2182-2193. PubMed ID: 32710190
[TBL] [Abstract][Full Text] [Related]
2. The epigenetic signature of systemic insulin resistance in obese women.
Arner P; Sahlqvist AS; Sinha I; Xu H; Yao X; Waterworth D; Rajpal D; Loomis AK; Freudenberg JM; Johnson T; Thorell A; Näslund E; Ryden M; Dahlman I
Diabetologia; 2016 Nov; 59(11):2393-2405. PubMed ID: 27535281
[TBL] [Abstract][Full Text] [Related]
3. Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes.
Abderrahmani A; Yengo L; Caiazzo R; Canouil M; Cauchi S; Raverdy V; Plaisance V; Pawlowski V; Lobbens S; Maillet J; Rolland L; Boutry R; Queniat G; Kwapich M; Tenenbaum M; Bricambert J; Saussenthaler S; Anthony E; Jha P; Derop J; Sand O; Rabearivelo I; Leloire A; Pigeyre M; Daujat-Chavanieu M; Gerbal-Chaloin S; Dayeh T; Lassailly G; Mathurin P; Staels B; Auwerx J; Schürmann A; Postic C; Schafmayer C; Hampe J; Bonnefond A; Pattou F; Froguel P
Diabetes; 2018 Jul; 67(7):1310-1321. PubMed ID: 29728363
[TBL] [Abstract][Full Text] [Related]
4. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.
Longo M; Raciti GA; Zatterale F; Parrillo L; Desiderio A; Spinelli R; Hammarstedt A; Hedjazifar S; Hoffmann JM; Nigro C; Mirra P; Fiory F; Formisano P; Miele C; Smith U; Beguinot F
Diabetologia; 2018 Feb; 61(2):369-380. PubMed ID: 29067487
[TBL] [Abstract][Full Text] [Related]
6. Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver.
García-Calzón S; Perfilyev A; Männistö V; de Mello VD; Nilsson E; Pihlajamäki J; Ling C
Clin Epigenetics; 2017; 9():102. PubMed ID: 28947922
[TBL] [Abstract][Full Text] [Related]
7. An antisense transcript transcribed from Irs2 locus contributes to the pathogenesis of hepatic steatosis in insulin resistance.
Matsushita M; Awazawa M; Kobayashi N; Ikushima YM; Soeda K; Tamura-Nakano M; Muratani M; Kobayashi K; Blüher M; Brüning JC; Ueki K
Cell Chem Biol; 2022 Apr; 29(4):680-689.e6. PubMed ID: 34986326
[TBL] [Abstract][Full Text] [Related]
8. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
[TBL] [Abstract][Full Text] [Related]
9. miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle.
Agarwal P; Srivastava R; Srivastava AK; Ali S; Datta M
Biochim Biophys Acta; 2013 Aug; 1832(8):1294-303. PubMed ID: 23579070
[TBL] [Abstract][Full Text] [Related]
10. Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.
Enooku K; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Tsutsumi T; Nakagomi R; Minami T; Sato M; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Fukayama M; Koike K
J Gastroenterol; 2018 Dec; 53(12):1261-1275. PubMed ID: 29749571
[TBL] [Abstract][Full Text] [Related]
11. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 and SIRT7 expression in adipose tissues of obese and normal-weight individuals is regulated by microRNAs but not by methylation status.
Kurylowicz A; Owczarz M; Polosak J; Jonas MI; Lisik W; Jonas M; Chmura A; Puzianowska-Kuznicka M
Int J Obes (Lond); 2016 Nov; 40(11):1635-1642. PubMed ID: 27480132
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter.
Sookoian S; Rosselli MS; Gemma C; Burgueño AL; Fernández Gianotti T; Castaño GO; Pirola CJ
Hepatology; 2010 Dec; 52(6):1992-2000. PubMed ID: 20890895
[TBL] [Abstract][Full Text] [Related]
16. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.
Latorre J; Moreno-Navarrete JM; Mercader JM; Sabater M; Rovira Ò; Gironès J; Ricart W; Fernández-Real JM; Ortega FJ
Int J Obes (Lond); 2017 Apr; 41(4):620-630. PubMed ID: 28119530
[TBL] [Abstract][Full Text] [Related]
17. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity.
Kubota N; Kubota T; Kajiwara E; Iwamura T; Kumagai H; Watanabe T; Inoue M; Takamoto I; Sasako T; Kumagai K; Kohjima M; Nakamuta M; Moroi M; Sugi K; Noda T; Terauchi Y; Ueki K; Kadowaki T
Nat Commun; 2016 Oct; 7():12977. PubMed ID: 27708333
[TBL] [Abstract][Full Text] [Related]
18. Liver saturated fat content associates with hepatic DNA methylation in obese individuals.
Sehgal R; Perfilyev A; Männistö V; Ågren J; Nilsson E; Käkelä P; Ling C; de Mello VD; Pihlajamäki J
Clin Epigenetics; 2023 Feb; 15(1):21. PubMed ID: 36765383
[TBL] [Abstract][Full Text] [Related]
19. Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle.
Rönn T; Poulsen P; Hansson O; Holmkvist J; Almgren P; Nilsson P; Tuomi T; Isomaa B; Groop L; Vaag A; Ling C
Diabetologia; 2008 Jul; 51(7):1159-68. PubMed ID: 18488190
[TBL] [Abstract][Full Text] [Related]
20. Identification of a single nucleotide polymorphism showing no insulin-mediated suppression of the promoter activity in the human insulin receptor substrate 2 gene.
Iwamoto K; Mori H; Okazawa H; Hashiramoto M; Kasuga M
Diabetologia; 2002 Aug; 45(8):1182-95. PubMed ID: 12189449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
